FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

The summary for the FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed): The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.

Federal Grant Title:	FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Federal Agency Name:	Food and Drug Administration (HHS-FDA)
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-23-072
Type of Funding:	Grant
CFDA Numbers:	93.103
CFDA Descriptions:	Information not provided
Current Application Deadline:	October 10th, 2025
Original Application Deadline:	October 10th, 2025
Posted Date:	December 13th, 2022
Creation Date:	December 13th, 2022
Archive Date:	November 9th, 2025
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	20
Cost Sharing or Matching:	No
Last Updated:	December 13th, 2022

Applicants Eligible for this Grant: County governments - City or township governments - Independent school districts - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - For-profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Foreign Institutions are not eligible to apply
Link to Full Grant Announcement: Full Announcement of PAR-23-072
Grant Announcement Contact: Janelle Fundersburg
Grantor
Phone 301-798-2533
[email protected]
Similar Government Grants: • Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional; • Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinic...; • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...; • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...; • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...; • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration: • Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional; • Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinic...; • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...